Study on Patient Blood Management in Haematological Patients

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT03217370
• Date of registration: 05/07/2017
• Prospective Registration: Yes
• Primary sponsor: Universitaire Ziekenhuizen Leuven
• Public title: Study on Patient Blood Management in Haematological Patients
• Scientific title: Study on Patient Blood Management in Haematological Patients
• Date of first enrolment: August 1, 2017
• Target sample size: 700
• Recruitment status: Suspended
• URL: https://clinicaltrials.gov/show/NCT03217370
• Study type: Interventional
• Study design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
• Phase: N/A

Countries of recruitment

Belgium

Contacts

• Name: Els Costermans, MD
• Affiliation: advanced clinical nurse specialist

Key inclusion & exclusion criteria

Inclusion Criteria:

- all adult patients hospitalised at the haematology wards of the University Hospitals
of Leuven (UZ Leuven) between 01/08/2017 and 31/07/2018 (pre measurement) and between
between 01/08/2019 and 31/07/2020 (post measurement)

Exclusion Criteria:

- ambulatory patients

- patients without blood transfusion administered in their hospitalised period

- patients with no haematological illness that were hospitalised at the haematological
wards



Age minimum: N/A
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Blood Transfusion

Haematology

Intervention(s)

Other: education of guidelines

Primary Outcome(s)

how do haematologists prescribe blood components? [Time Frame: up to 1 year pre measurement and up to 1 year post measurement]

Secondary Outcome(s)

what's the effect of the interventional phase? [Time Frame: up to 1 year (post measurement)]

Secondary ID(s)

S60580

Source(s) of Monetary Support

Please refer to primary and secondary sponsors